Leaflet GRANISETRON TEVA 1mg / 1ml concentrate for solution for injection / infusion

Product code:
W53091002
Quantity:
5
Indicated for:
chemotherapy-induced nausea and vomiting
Route of administration:
injectable / infusion
Substance:
granisetron (antiemetic)
ATC
A04AA02 — Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists
Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANISETRON TEVA 1mg / 1ml

Substance:
granisetron
Date of latest medicines list:
01-07-2020
Product code:
W53091002
Concentration:
1mg / 1ml
Pharmaceutical form:
concentrate for solution for injection / infusion
Packing volume:
1ml
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
TEVA UK LIMITED - MAREA BRITANIE
Holder:
TEVA PHARMACEUTICALS S.R.L. - ROMANIA
Number:
6088/2014/02
Shelf life:
3 years-after packing for marketing;dupa dilutie-it is used immediately

Concentrations available for granisetron

  • 1mg
  • 1mg/1ml
  • 1mg/ml
  • 20mcg/ml
  • 2mg
  • 3.1mg/24h
  • 3mg/3ml